Pharmaceutical company names former AstraZeneca exec new CEO, founder to retire
An industry veteran who once led a division of AstraZeneca will step into role. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 19, 2023 Category: Biotechnology Authors: Ashley Portero Source Type: news
ESMO Abstract Leak Reveals Promising NSCLC Therapies from BMS, BeiGene, J & J, Mirati
Pictured: Illustration of a tumor in the lungs/iStock, Mohammed Haneefa Nizamudeen Following an embargo breach, the organizers of the upcoming European Society for Medical Oncology Congress 2023 on Tuesday made available all late-breaking abstracts to be presented during the meeting. The decision…#nsclc #bristolmyerssquibb #opdivo #johnsonjohnson #astrazeneca #tagrisso #biospace #spain #bms #checkmate (Source: Reuters: Health)
Source: Reuters: Health - October 19, 2023 Category: Consumer Health News Source Type: news
Esketamine Bests Quetiapine for Resistant Depression Esketamine Bests Quetiapine for Resistant Depression
Intranasal esketamine (Spravato, Janssen) is superior to extended-release quetiapine (Seroquel, AstraZeneca) for treatment-resistant depression, results of a multicenter, head-to-head phase 3 trial show.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 10, 2023 Category: Consumer Health News Tags: Psychiatry News Source Type: news
$425M Heartburn Drug Settlement; 5 Years for Clinic Fire; $2.5M Broken Leg Award
(MedPage Today) -- AstraZeneca will pay $425 million to settle lawsuits alleging that patients suffered kidney injuries while using its heartburn drugs esomeprazole (Nexium) and omeprazole (Prilosec). (The Hill)
A 22-year-old woman was sentenced... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - October 5, 2023 Category: American Health Source Type: news
Immunity-enhancing cocktail protects mice against multiple hospital germs
Some people in hospital die not from the illness or accident that got them admitted but from germs they catch once there. In the United States alone, there are hundreds of thousands of hospital-acquired infections each year, leading to tens of thousands of deaths. Seeking to lower this toll, researchers have now come up with an
immune-boosting cocktail that increases the survival
of mice exposed to the microbes responsible.
The three-compound formulation, which the researchers unusually refer to as a vaccine, provided up to 28 days of protection from the notorious hospital bacterium
Pseudomonas aerugin...
Source: ScienceNOW - October 4, 2023 Category: Science Source Type: news
AstraZeneca's Dr. Heather McDonald Discusses HEOR and Market Access in Today's Drug Development Landscape, Featured Interview by Xtalks
Challenges in health economics and market access are universal, affecting large pharmaceutical companies and small biotech startups alike. In this article, Xtalks spoke with Dr. Heather McDonald, PhD, VP of Market Access and Pricing at AstraZeneca, to understand the challenges of HEOR and... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 4, 2023 Category: Pharmaceuticals Source Type: news
AstraZeneca Settles Lawsuits Alleging Heartburn Drugs Caused Kidney Disease For $425 Million
The payout will settle the claims of 11,000 people who said they weren ’t property warned Nexium and Prilosec could cause chronic kidney disease. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 3, 2023 Category: Pharmaceuticals Authors: Mary Whitfill Roeloffs, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news topline Source Type: news
AstraZeneca gets CDSCO approval for preventive therapy for respiratory syncytial virus
This innovative therapy is indicated for prevention of serious lower respiratory tract disease requiring hospitalisation caused by Respiratory Syncytial Virus (RSV) in children at high risk of RSV disease, it added. RSV is a public health challenge faced across the globe today and is the second most common cause of death in children under 1 year of age. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 30, 2023 Category: Pharmaceuticals Source Type: news
Cancer Drug Shortages for Kids; Pharma Agrees to Price Talks; Catch-Up on Screening
(MedPage Today) -- Despite ongoing efforts to overcome shortages of cancer drugs, many hospitals report critically low supplies of drugs to treat leukemia and lymphoma in children. (NBC News)
Reluctantly, AstraZeneca, Bristol Myers Squibb, and... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - September 28, 2023 Category: Hematology Source Type: news
Covid vaccines DO cause unexpected vaginal bleeding in women - even if they haven't had their period in YEARS, study finds
Norwegian researchers found the Pfizer, Moderna and AstraZeneca Covid-19 vaccines are associated with unexpected vaginal bleeding in older women and women on birth control. (Source: the Mail online | Health)
Source: the Mail online | Health - September 26, 2023 Category: Consumer Health News Source Type: news
AstraZeneca Surges As It Takes A Shot At Gilead's Second-Biggest Cancer Drug
and Daiichi Sankyo said Friday their breast cancer treatment outperformed chemotherapy in a Phase 3 study, and AZN stock jumped to its 50-day line. The companies are in the antibody drug conjugate, or ADC, space with a medicine called datopotamab deruxteca. ADCs are like smart bombs, targeting…#daiichisankyo #azn #astrazeneca #adc #marketsmithcom #trodelvy #gileadsciences #gild #isi #umerraffat (Source: Reuters: Health)
Source: Reuters: Health - September 22, 2023 Category: Consumer Health News Source Type: news
Stocks making the biggest moves premarket: AstraZeneca, Wayfair, Alibaba and more
A paramedic prepares doses of AstraZeneca vaccine for patients at a walk-in COVID-19 clinic inside a Buddhist temple in the Smithfield suburb of Sydney on August 4, 2021. Check out the companies making headlines in early trading. AstraZeneca — Shares of the British pharmaceutical company gained…#astrazeneca #buddhist #smithfield #sydney #alibaba #pddholdings #seagen #deere #canaccordgenuity #armholdings (Source: Reuters: Health)
Source: Reuters: Health - September 22, 2023 Category: Consumer Health News Source Type: news
AstraZeneca, Daiichi post early win in Phase 3 trial for breast cancer therapy
(Source: Reuters: Health)
Source: Reuters: Health - September 22, 2023 Category: Consumer Health News Source Type: news
Asthma Market is Predicted to Exhibit Remarkable Growth by 2032, Predicts DelveInsight | Key Companies to Look Out - GlaxoSmithKline, AstraZeneca, Sanofi, Roche, Amgen, Regeneron, Incyte, Areteia, Suzhou Connect, Cumberland, Pulmatrix
The asthma market will boost during the forecast period (2023–2032) due to improvement in diagnosis over the globe and thus the surge in treatment options along with the expected launch of emerging therapies, for asthma treatment. LAS VEGAS, Sept. 14, 2023 /PRNewswire/ -- DelveInsight's... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 14, 2023 Category: Pharmaceuticals Tags: MRR Source Type: news
Costing an Arm
As the Cambridge-based semiconductor designer and British tech success story, Arm, goes up for sale on the Nasdaq - Felicity Hannah finds out why it's set to be the biggest IPO of the year, and if it will live up to the hype. The pharmaceutical company AstraZeneca is upgrading two of its UK sites…#cambridge #astrazeneca #manchestercitywomen (Source: Reuters: Health)
Source: Reuters: Health - September 14, 2023 Category: Consumer Health News Source Type: news
